Telus is one of Canada’s Big Three telecom service providers, offering wireless and broadband services nationally, but with strongholds in British Columbia and Alberta... Show more
TELUS has long differentiated itself within Canadian telecom through premium bundled offerings, industry-leading customer loyalty, and a diversified portfolio that extends well beyond wireless and wireline connectivity. Its postpaid mobile phone churn has remained below 1% for more than a decade, a loyalty advantage that underpins customer lifetime value and supports its premium-brand strategy.
The company's medium-term positioning increasingly rests on three pillars beyond traditional telecom: TELUS Health, TELUS Agriculture & Consumer Goods, and TELUS Digital, which was privatized in October 2025. TELUS Health in particular has become a genuine global growth business, while TELUS Digital now anchors an enterprise-wide AI and data strategy. This diversification is a structural strength, but it also exposes the company to integration risk and higher near-term complexity as management balances a mature, capital-intensive telecom core against faster-growing but less predictable digital businesses.
A critical structural challenge is elevated leverage following years of heavy network investment. TELUS's copper-to-fiber transition and 5G buildout have been capital-intensive, and the market has increasingly focused on the balance sheet rather than subscriber growth. Management's pivot toward capital-intensity moderation — targeting roughly 10% of revenue — and asset monetization is central to restoring confidence in the company's market positioning.
Several catalysts could shape investor sentiment in the quarters ahead. The most immediate is the trajectory of free cash flow. TELUS guided to consolidated free cash flow of approximately $2.45 billion for 2026 (about 10% growth) and a minimum 10% compound annual growth rate through 2028. Free cash flow rose 19% year over year in the first quarter of 2026, a positive signal for debt reduction and dividend coverage.
A second catalyst is potential monetization of TELUS Health. Management has publicly signaled strategic partnership opportunities, and the outcome could materially alter the balance sheet and unlock value — or, if delayed, prolong leverage concerns. Relatedly, progress on the broader $7 billion monetization program, including real estate and copper infrastructure sales, will be closely watched.
The AI and Sovereign AI Factory expansion is another swing factor. TELUS's first facility in Rimouski, Quebec, sold out within months, and a second facility in Kamloops, British Columbia, is coming online. Whether these assets convert early demand into durable, high-margin revenue will test the credibility of the $2 billion 2028 AI-revenue ambition.
On analyst ratings, the consensus profile remains predominantly positive but has softened at the margins. TD Cowen, RBC Capital, National Bank, CIBC, and Desjardins have maintained Buy or Outperform ratings with price targets ranging from roughly C$21 to C$26, while BMO Capital downgraded TELUS to Hold in December 2025 and BofA Securities holds a Hold rating with a lowered target. As of late 2025, the average one-year price target stood near $16.51, with a range of approximately $13.75 to $19.56 — reflecting a generally constructive but cautious consensus.
TELUS operates in a mature, intensely promotional Canadian wireless market where competitors routinely use aggressive device discounts. This dynamic pressures ARPU (average revenue per user), although TELUS has reported decelerating ARPU declines and sequential improvement by preserving its premium positioning rather than chasing volume.
Interest rates are a defining macro variable. Higher borrowing costs amplify the burden of TELUS's elevated debt load, which is why deleveraging dominates the investment narrative. Any sustained easing in rates would directly support interest-cost reduction and improve free-cash-flow coverage of the dividend, while persistently higher rates would keep the balance sheet in focus.
Regulatory and policy developments also matter. Canadian telecom is shaped by spectrum auctions and government connectivity initiatives, and TELUS's positioning in sovereign AI infrastructure aligns with federal efforts to build domestic computing capacity — a potential tailwind. Geopolitical and currency dynamics add further sensitivity, given TELUS Digital's exposure to U.S.-dollar-denominated revenues.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool designed to help traders assess whether a stock, ETF, or other asset may trend bullish, bearish, or sideways over the next week or month. It is built to assist users in spotting developing trends, evaluating possible breakouts or reversals, and exploring predictions across a broad range of tradable instruments. The platform includes searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. For investors tracking TELUS's evolving story, the Trend Prediction Engine offers a complementary, data-driven lens for monitoring near-term momentum.
Heading into late 2026 and beyond, TELUS's outlook hinges on disciplined execution across three long-term themes. First, balance-sheet repair: achieving the 3.3-times leverage target by year-end 2026 and 3.0-times by 2027 would meaningfully de-risk the equity and support the dividend, which has been held flat as a deliberate capital-allocation choice.
Second, margin and cost-structure evolution. The TELUS Digital integration is expected to deliver $150 million to $200 million in annual cash synergies, with most realized in 2026, while moderating capital expenditures should raise free-cash-flow conversion over time.
Third, diversification into AI and health. If TELUS Health sustains double-digit growth and Sovereign AI Factories convert demand into recurring revenue, the company could gradually re-rate away from a pure telecom multiple. Competitive threats remain, however — an aggressive promotional environment, potential regulatory shifts, and execution risk around AI monetization could temper the trajectory.
Analyst price targets reflect cautious optimism rather than conviction. With consensus still tilting toward Buy and an average target implying upside from recent levels, the market appears to be waiting for sustained evidence of deleveraging and free-cash-flow durability before rewarding the stock more fully.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, TU has been loosely correlated with BCE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TU jumps, then BCE could also see price increases.
| Ticker / NAME | Correlation To TU | 1D Price Change % |
|---|---|---|
| TU | 100% | -3.29% |
| Major Telecommunications industry (58 stocks) | 18% Poorly correlated | +1.69% |
a provider of telecommunications products and services
Industry MajorTelecommunications
TU moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend. In 11 of 25 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 44%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on TU as a result. In 21 of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 30%.
The Moving Average Convergence Divergence (MACD) for TU just turned positive on October 13, 2026. Looking at past instances where TU's MACD turned positive, the stock continued to rise in 14 of 37 cases over the following month. The odds of a continued upward trend are 38%.
The 10-day moving average for TU crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 36%.
Following a +5.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where TU advanced for three days, in 117 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 42%.
The Aroon Indicator entered an Uptrend today. In 67 of 214 cases where TU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 31%.
The 10-day RSI Indicator for TU moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 15 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 58%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
TU broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. TU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.080) is normal, around the industry mean (2.292). P/E Ratio (-15.707) is within average values for comparable stocks, (-7.252). Projected Growth (PEG Ratio) (13.443) is also within normal values, averaging (8.005). Dividend Yield (0.060) settles around the average of (0.133) among similar stocks. P/S Ratio (0.951) is also within normal values, averaging (5.777).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.